Rosiglitazone decreases bone mass and bone marrow fat.
Harsløf T, Wamberg L, Møller L, Stødkilde-Jørgensen H, Ringgaard S, Pedersen SB, Langdahl BL.
Harsløf T, et al.
J Clin Endocrinol Metab. 2011 May;96(5):1541-8. doi: 10.1210/jc.2010-2077. Epub 2011 Mar 2.
J Clin Endocrinol Metab. 2011.
PMID: 21367933
Clinical Trial.